Therapeutic Strategies for Hereditary Kidney Cancer

被引：0
作者：
Abhinav Sidana
Ramaprasad Srinivasan
机构：
[1] National Cancer Institute,Urologic Oncology Branch, Center for Cancer Research
来源：
Current Oncology Reports | 2016年 / 18卷
关键词：
Renal cell cancer; Hereditary; Inherited; Kidney cancer; Clear cell renal cell cancer; Papillary renal cell cancer; Tyrosine kinase inhibitors; Von Hippel-Lindau; HLRCC; HPRC; Tuberous sclerosis; Metastatic; Fumarate hydratase; Succinate dehydrogenase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The study of hereditary forms of kidney cancer has vastly increased our understanding of metabolic and genetic pathways involved in the development of both inherited and sporadic kidney cancers. The recognition that diverse molecular events drive different forms of kidney cancers has led to the preclinical and clinical development of specific pathway-directed strategies tailored to treat distinct subgroups of kidney cancer. Here, we describe the molecular mechanisms underlying the pathogenesis of several different types of hereditary renal cancers, review their clinical characteristics, and summarize the treatment strategies for the management of these cancers.
引用
收藏
相关论文
共 280 条
[21]  
Eisen T(2016)Comprehensive molecular characterization of papillary renal-cell carcinoma N Engl J Med 374 135-45
[22]  
Maher ER(2015)Papillary renal cell carcinoma: a review of the current therapeutic landscape Crit Rev Oncol Hematol 96 100-12
[23]  
Walther MM(2013)Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches Semin Oncol 40 511-20
[24]  
Lubensky IA(2013)Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma J Clin Oncol 31 181-6
[25]  
Venzon D(2001)Inherited susceptibility to uterine leiomyomas and renal cell cancer Proc Natl Acad Sci U S A 98 3387-92
[26]  
Zbar B(1994)Hereditary papillary renal cell carcinoma J Urol 151 561-6
[27]  
Linehan WM(2007)The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome Am J Surg Pathol 31 1578-85
[28]  
Duan DR(2003)Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America Am J Hum Genet 73 95-106
[29]  
Pause A(2009)Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species Mol Cell Biol 29 4080-90
[30]  
Burgess WH(2013)Aerobic glycolysis: a novel target in kidney cancer Expert Rev Anticancer Ther 13 711-9
12345678910